| Les deux révisions précédentes
Révision précédente
Prochaine révision
|
Révision précédente
|
start [2025/03/07 13:37]
remyfroissart [Present position & education] |
start [2025/06/17 21:04] (Version actuelle)
remyfroissart [Articles] |
| In 2014, I decided to come back on phage'evolution through a collaboration with [[ http://www.idm.uct.ac.za/Jo-Ann_Passmore|Jo-Ann Passmore]] (University of Cape-Town, South-Africa), [[ https://virostyle.cnrs.fr/team/ignacio-bravo/|Ignacio Bravo]] (MIVEGEC, Montpellier, France) and [[ https://marievasse.eu/|Marie Vasse]] (post-doc, MIVEGEC, Marie-Curie grant) with whom we are working on disturbance of microbial vaginal ecosystem that may results on dysbiosis (in particular, bacterial vaginosis). | In 2014, I decided to come back on phage'evolution through a collaboration with [[ http://www.idm.uct.ac.za/Jo-Ann_Passmore|Jo-Ann Passmore]] (University of Cape-Town, South-Africa), [[ https://virostyle.cnrs.fr/team/ignacio-bravo/|Ignacio Bravo]] (MIVEGEC, Montpellier, France) and [[ https://marievasse.eu/|Marie Vasse]] (post-doc, MIVEGEC, Marie-Curie grant) with whom we are working on disturbance of microbial vaginal ecosystem that may results on dysbiosis (in particular, bacterial vaginosis). |
| |
| I also work with [[ https://isem-evolution.fr/membre/martin/|Guillaume Martin]] (CNRS, ISEM, Montpellier, France) and [[ https://www.researchgate.net/profile/Yoann-Anciaux|Yoann Anciaux]] (post-doc ISEM-MIVEGEC, Montpellier, France) on //in vitro// evolutionary rescue of bacteria stressed by antibiotics and/or bacteriophages targetting //E.coli//. I also participate to the project [[ https://www.chu-lyon.fr/antibioresistance-projet-phag-one|Phag-One]] leaded by Frederic Laurent and Tristan Ferry ([[ https://www.crioac-lyon.fr/phagotherapie-bacteriophage/|Hospice Civile de Lyon]]) on the bacteriophage' host-range targetting //Staphylococcus epidermidis// and //E.coli//. Finally, I'm currently also working on //Salmonella// 'bacteriophages in order to perform long-term efficiency of bacteriophage biocontrol. | I also work with [[ https://isem-evolution.fr/membre/martin/|Guillaume Martin]] (CNRS, ISEM, Montpellier, France) on //in vitro// evolutionary rescue of bacteria stressed by antibiotics and/or bacteriophages targetting //E.coli//. I also participate to the project [[ https://www.chu-lyon.fr/antibioresistance-projet-phag-one|Phag-One]] leaded by Frederic Laurent and Tristan Ferry ([[ https://www.crioac-lyon.fr/phagotherapie-bacteriophage/|Hospice Civile de Lyon]]) on the bacteriophage' host-range targetting //Staphylococcus epidermidis// and //E.coli//. Finally, I'm currently also working on //Salmonella// 'bacteriophages in order to perform long-term efficiency of bacteriophage biocontrol. |
| | |
| | ===== Areas of expertise ===== |
| | * evolutionary virology |
| | * experimental evolution |
| | * adaptation |
| | * evolution in heterogeneous environment (spatial / temporal heterogeneity) |
| | * evolution towards specialisation / generalism |
| | * phage therapy and biocontrol |
| |
| ====== Collective scientific responsabilities ====== | ====== Collective scientific responsabilities ====== |
| * Elected representant to the logistic group of MIVEGEC (2018- ) | * Elected representant to the logistic group of MIVEGEC (2018- ) |
| * Scientific responsible for the laboratory security (level L2) of MIVEGEC (2016- ) | * Scientific responsible for the laboratory security (level L2) of MIVEGEC (2016- ) |
| * APA Correspondant (Nagoya protocol) for MIVEGEC (2021- ) | |
| * Participant of the Science ecological councern group of MIVEGEC (MIVEGEC-1.5) | * Participant of the Science ecological councern group of MIVEGEC (MIVEGEC-1.5) |
| |
| ° Authors contributed equally to the work | ° Authors contributed equally to the work |
| # corresponding author(s) | # corresponding author(s) |
| | |
| | |
| | ===2025=== |
| | * Maurin A., C. Zarate-Chaves, C. Breyton, J. Dainat, A. Feugier & R. Froissart. 2025. « [[https://www.biorxiv.org/cgi/content/short/2025.06.16.659957v1|The complete genome and comparative analysis of a new Tequintavirus: Salmonella phage Tennessee Salten]] ». **BioRxiv** |
| |
| ===2024=== | ===2024=== |
| * Brives C, R. Froissart, B. Perez-Sepulveda & C. Le Marrec. 2024. « [[https://doi.org/10.1089/phage.2023.0047|Thinking Phage Innovations Through Evolution and Ecology]] ». **PHAGE** 5(1) | * Brives C, R. Froissart, B. Perez-Sepulveda & C. Le Marrec. 2024. « [[https://doi.org/10.1089/phage.2023.0047|Thinking Phage Innovations Through Evolution and Ecology]] ». **PHAGE** 5(1) |
| * Maurin A., M. Vasse, C. Breyton, C. Zarate-Chaves, S. Bouzidi, J. Hayer, J. Dainat, Margaux Mesleard-Roux, F-X. Weill, I. G. Bravo, A. Feugier & R. Froissart. 2024. « [[https://doi.org/10.1101/2024.03.13.584857|“This training is bound for glory” : selection by experimental evolution of a bacteriophage with expanded host-range and increased virulence]]. **BioRxiv** | * Maurin A., M. Vasse, C. Breyton, C. Zarate-Chaves, S. Bouzidi, J. Hayer, J. Dainat, Margaux Mesleard-Roux, F-X. Weill, I. G. Bravo, A. Feugier & R. Froissart. 2024. « [[https://doi.org/10.1101/2024.03.13.584857|“This training is bound for glory” : selection by experimental evolution of a bacteriophage with expanded host-range and increased virulence]] ». **BioRxiv** |
| |
| ===2022=== | ===2022=== |
